A groundbreaking study reveals that beta blockers may not benefit heart attack patients with preserved heart function. Discover the surprising results that could change treatment protocols.
A historic pig lung transplant into a brain-dead human patient lasted nine days, showcasing the potential and challenges of xenotransplantation. While the patient faced organ rejection, this experiment opens new avenues in medical science.
Eli Lilly's new obesity pill, orforglipron, faces tough competition but could disrupt the weight loss market. Despite underwhelming trial results, analysts see potential for success due to manufacturing advantages and pricing strategies.
A groundbreaking study reveals that a new mRNA vaccine can activate the immune system and significantly shrink tumors in mice, sparking hope for a universal cancer vaccine that could revolutionize treatment methods.
A groundbreaking Harvard study suggests lithium may reverse Alzheimer's-like changes in mice, igniting hope among advocates for earlier detection and new treatments. Experts urge caution and further research.
As gene therapy for Duchenne muscular dystrophy faces scrutiny after tragic deaths, families like the Revells navigate the uncertain waters of hope and risk, questioning the future of their loved ones.
In a stunning move, the FDA has put clinical trials for Sarepta's gene therapy on hold due to alarming safety concerns after multiple patient deaths linked to acute liver failure. The company faces scrutiny as it navigates the fallout.
Sarepta Therapeutics is under fire as another patient succumbs to acute liver failure linked to its gene therapy trial for muscular dystrophy, adding to the recent deaths of two teenage boys.
Isomorphic Labs, leveraging AI breakthroughs from DeepMind, is on the brink of human clinical trials for cancer drugs. With major pharma partnerships, the future of drug design looks promising!
A groundbreaking study reveals that a blood test can identify Alzheimer's patients at risk of rapid decline. Researchers highlight the importance of insulin resistance in accelerating cognitive impairment, opening doors for timely interventions.
